The following is the full transcript of the interview with International Atomic Energy Agency Director-General Rafael Grossi, ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Christian Arnell Christensen & Associates. Today's presentation will be conducted in English and will consist of prepared remarks reviewing the group's financial and operational p ...

Q3 2026 Earnings Call March 19, 2026 5:30 PM EDTCompany ParticipantsJenifer Hollander - Vice President of Investor ...

The newly-released product addresses the issues of expert availability, schedule alignment, and regular feedback ...

Dustin Hilliary, co-CEO of Hilliary Communications, was appointed to the University of Oklahoma Board of Regents Thursday by ...

Relmada Therapeutics Inc (RLMD) reports significant progress in clinical trials and financial strategies, despite increased net loss and administrative expenses.

Scholastic Corporation (NASDAQ:SCHL) delivered results in line with expectations while using a major $400 million ...

Lesley Cordero discusses platform engineering as a practice for driving sociotechnical change and organizational ...

Yet, traditional ITSM frameworks often rely heavily on manual processes that create inefficiencies, accuracy issues, and slow resolution times. As organizations scale and user demands grow more ...